315 related articles for article (PubMed ID: 19929031)
1. Polypharmacy status as an indicator of mortality in an elderly population.
Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S
Drugs Aging; 2009; 26(12):1039-48. PubMed ID: 19929031
[TBL] [Abstract][Full Text] [Related]
2. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis.
Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S
Drugs Aging; 2009; 26(6):493-503. PubMed ID: 19591524
[TBL] [Abstract][Full Text] [Related]
3. Polypharmacy in the Elderly: A Marker of Increased Risk of Mortality in a Population-Based Prospective Study (NEDICES).
Gómez C; Vega-Quiroga S; Bermejo-Pareja F; Medrano MJ; Louis ED; Benito-León J
Gerontology; 2015; 61(4):301-9. PubMed ID: 25502492
[TBL] [Abstract][Full Text] [Related]
4. Survival of the elderly and exposition to polypharmacy in the city of São Paulo, Brazil: SABE Study.
Romano-Lieber NS; Corona LP; Marques LFG; Secoli SR
Rev Bras Epidemiol; 2019 Feb; 21Suppl 02(Suppl 02):e180006. PubMed ID: 30726351
[TBL] [Abstract][Full Text] [Related]
5. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study.
Jyrkkä J; Vartiainen L; Hartikainen S; Sulkava R; Enlund H
Eur J Clin Pharmacol; 2006 Feb; 62(2):151-8. PubMed ID: 16408226
[TBL] [Abstract][Full Text] [Related]
6. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people.
Herr M; Robine JM; Pinot J; Arvieu JJ; Ankri J
Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):637-46. PubMed ID: 25858336
[TBL] [Abstract][Full Text] [Related]
7. Frailty, Polypharmacy, and Health Outcomes in Older Adults: The Frailty and Dependence in Albacete Study.
Bonaga B; Sánchez-Jurado PM; Martínez-Reig M; Ariza G; Rodríguez-Mañas L; Gnjidic D; Salvador T; Abizanda P
J Am Med Dir Assoc; 2018 Jan; 19(1):46-52. PubMed ID: 28899661
[TBL] [Abstract][Full Text] [Related]
8. Potentially inappropriate medications with polypharmacy increase the risk of falls in older Japanese patients: 1-year prospective cohort study.
Masumoto S; Sato M; Maeno T; Ichinohe Y; Maeno T
Geriatr Gerontol Int; 2018 Jul; 18(7):1064-1070. PubMed ID: 29582533
[TBL] [Abstract][Full Text] [Related]
9. Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: a six-year follow-up.
Tuikkala P; Hartikainen S; Korhonen MJ; Lavikainen P; Kettunen R; Sulkava R; Enlund H
Scand J Prim Health Care; 2010 Jun; 28(2):121-7. PubMed ID: 20470020
[TBL] [Abstract][Full Text] [Related]
10. Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study.
Wimmer BC; Bell JS; Fastbom J; Wiese MD; Johnell K
Ann Pharmacother; 2016 Feb; 50(2):89-95. PubMed ID: 26681444
[TBL] [Abstract][Full Text] [Related]
11. Potentially inappropriate medications for the elderly: Incidence and impact on mortality in a cohort ten-year follow-up.
de Araújo NC; Silveira EA; Mota BG; Neves Mota JP; de Camargo Silva AEB; Alves Guimarães R; Pagotto V
PLoS One; 2020; 15(10):e0240104. PubMed ID: 33112864
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or =77 years in Sweden.
Haider SI; Johnell K; Thorslund M; Fastbom J
Clin Ther; 2008 Feb; 30(2):419-27. PubMed ID: 18343279
[TBL] [Abstract][Full Text] [Related]
13. Excessive polypharmacy and survival in polypathological patients.
Díez-Manglano J; Giménez-López M; Garcés-Horna V; Sevil-Puras M; Castellar-Otín E; González-García P; Fiteni-Mera I; Morlanes-Navarro T;
Eur J Clin Pharmacol; 2015 Jun; 71(6):733-739. PubMed ID: 25911439
[TBL] [Abstract][Full Text] [Related]
14. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
Porter B; Arthur A; Savva GM
BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
[TBL] [Abstract][Full Text] [Related]
15. Variation over time in the association between polypharmacy and mortality in the older population.
Richardson K; Ananou A; Lafortune L; Brayne C; Matthews FE
Drugs Aging; 2011 Jul; 28(7):547-60. PubMed ID: 21721599
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.
Schöttker B; Saum KU; Muhlack DC; Hoppe LK; Holleczek B; Brenner H
Eur J Clin Pharmacol; 2017 Aug; 73(8):1041-1048. PubMed ID: 28540438
[TBL] [Abstract][Full Text] [Related]
17. Association of healthy lifestyle and all-cause mortality according to medication burden.
Kelly NA; Soroka O; Onyebeke C; Pinheiro LC; Banerjee S; Safford MM; Goyal P
J Am Geriatr Soc; 2022 Feb; 70(2):415-428. PubMed ID: 34695226
[TBL] [Abstract][Full Text] [Related]
18. [Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A; Bellini P; Terracini B;
Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy is differentially associated with 20-year mortality among community-dwelling elderly women and men: The Israel Glucose Intolerance, Obesity and Hypertension cohort study.
Orenstein L; Chetrit A; Goldman A; Novikov I; Dankner R
Mech Ageing Dev; 2023 Apr; 211():111788. PubMed ID: 36758642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
